Cholesterol drug setback casts doubt over multibillion-dollar race
--------------------------------------------------------------------
Source: CNBC
Published: 2026-09-08 15:00 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Law & Courts, Drugs, Crime & Justice
--------------------------------------------------------------------
Snippet:
Novartis' failure in a closely watched cardiovascular trial has raised questions about one of the pharmaceutical industry's biggest drug races and rival treatments from U.S. heavyweights Amgen and Eli Lilly.
--------------------------------------------------------------------